This post refers to two intriguing presentations of this year’s EACTS meeting, held in Vienna. Both presentations deal with the chronically ischemic mitral valve (graded at least moderate) as a concomitant finding in patients qualifying for coronary artery bypass grafting. The indication for revascularization is an important differentiator: chronic mitral regurgitation due to past myocardial infarction can also be an entity by itself (i.e. without the need for a revascularization procedure). This entity poses a delicate and difficult question on the best option of how to deal with it. Surgery does not always deliver the desired result, the newer interventional option of Mitraclip® is currently in evolving investigation. I will come back to this issue with a dedicated post. Stay tuned!
Our clinical situation:
There is a plenty of meetings and conferences focusing on cardiology / cardiac surgery every year. Too many, actually. One of the most important ones in terms of participants and scientific impact is the annual meeting of the European Society of Cardio-Thoracic Surgery (EACTS). In many aspects, I believe it is better and more innovative than the big, classic american cardiac surgery meetings, such as the ones of the Society of Thoracic Surgeons (STS) or of the American Association of Thoracic Surgery (AATS).
In the following posts (all tagged “EACTS_2013”) I will review and share my favorite presentations of this years meeting. I will describe in a few sentences the clinical background to put the presentationsinto their context. Hopefully this will make the topics better understandable for you.